Elkfork Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$598K Hold
11,704
0.01% 529
2019
Q2
$495K Hold
11,704
0.01% 579
2019
Q1
$578K Hold
11,704
0.01% 522
2018
Q4
$506K Hold
11,704
0.01% 512
2018
Q3
$664K Buy
11,704
+2,240
+24% +$118K 0.02% 505
2018
Q2
$478K Hold
9,464
0.01% 542
2018
Q1
$471K Hold
9,464
0.01% 542
2017
Q4
$389K Buy
9,464
+1,456
+18% +$51K 0.01% 610
2017
Q3
$238K Buy
8,008
+1,008
+14% +$30.8K 0.01% 680
2017
Q2
$232K Buy
7,000
+3,164
+82% +$99.4K 0.01% 650
2017
Q1
$114K Buy
+3,836
New +$105K ﹤0.01% 716

Other funds holding GMED

Elkfork Partners's GMED Position: Q3 2019 in Review

Elkfork Partners held its Globus Medical (GMED) position steady in Q3 2019 at 11,704 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #529.

Elkfork Partners first reported a position in GMED in Q1 2017 and has held it in 11 quarters since. The position peaked at $664K in Q3 2018. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

  • Elkfork Partners held 11,704 shares of Globus Medical worth $598K as of Q3 2019.
  • Elkfork Partners left its Globus Medical share count unchanged in Q3 2019.
  • Globus Medical made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #529 holding.
  • Elkfork Partners first reported a position in Globus Medical in Q1 2017 and has held it in 11 quarters since.
  • Elkfork Partners's Globus Medical position peaked at $664K in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.